During the past decade, NJ Heart conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 6 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 3 clinical trials were completed. i.e. 60% of trials that started reached the finish line.

Out of the total clinical trials conducted in "NJ Heart" #1 sponsor was "Bayer" with 2 trials, followed by "Gilead Sciences" with 2 trials sponsored, "Pfizer" with 2 trials sponsored, "Brigham and Women's Hospital" with 1 trials sponsored and "Bristol-Myers Squibb" with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "NJ Heart" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 2 trials as a collaborator, "Boehringer Ingelheim" with 1 trials as a collaborator, "Brigham and Women's Hospital" with 1 trials as a collaborator, "Duke Clinical Research Institute" with 1 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "NJ Heart" are "Cardiovascular Disease" (4 trials), "Cardiovascular Diseases" (2 trials), "Heart Failure" (2 trials), "Hypertension" (2 trials) and "Obesity" (2 trials). Many other conditions were trialed in "NJ Heart" in a lesser frequency.

Most popular intervention types in "NJ Heart" are "Drug" (13 trials), "Other" (3 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Apixaban" (2 trials), "Darusentan" (2 trials), "Guanfacine" (2 trials) and "bococizumab (PF-04950615)" (2 trials). Other intervention names were less common.

The vast majority of trials in "NJ Heart" are 15 trials for "All" genders.

Currently, there are NaN active trials in "NJ Heart". undefined are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in NJ Heart, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in NJ Heart, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".